The downregulated membrane expression of CD18 in CD34


Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
28 04 2020
Historique:
received: 13 11 2018
accepted: 08 04 2020
revised: 18 03 2020
entrez: 30 4 2020
pubmed: 30 4 2020
medline: 22 6 2021
Statut: epublish

Résumé

CD18 is the common beta subunit of β Here we have analyzed the expression of CD18 in different subsets of human hematopoietic stem and progenitor cells (HSPCs) from cord blood (CB), bone marrow (BM), and mobilized peripheral blood (mPB) samples. CD34 A downregulated membrane expression of CD18 was associated with a primitive hematopoietic stem cells (HSC) phenotype, as well as with a higher content of quiescent cells and multipotent colony-forming cells (CFCs). Although no differences in the short-term repopulating potential of CD18 Overall, our results indicate that the downregulated membrane expression of CD18 characterizes a primitive population of human hematopoietic repopulating cells.

Sections du résumé

BACKGROUND
CD18 is the common beta subunit of β
METHODS
Here we have analyzed the expression of CD18 in different subsets of human hematopoietic stem and progenitor cells (HSPCs) from cord blood (CB), bone marrow (BM), and mobilized peripheral blood (mPB) samples. CD34
RESULTS
A downregulated membrane expression of CD18 was associated with a primitive hematopoietic stem cells (HSC) phenotype, as well as with a higher content of quiescent cells and multipotent colony-forming cells (CFCs). Although no differences in the short-term repopulating potential of CD18
CONCLUSIONS
Overall, our results indicate that the downregulated membrane expression of CD18 characterizes a primitive population of human hematopoietic repopulating cells.

Identifiants

pubmed: 32345365
doi: 10.1186/s13287-020-01672-0
pii: 10.1186/s13287-020-01672-0
pmc: PMC7189462
doi:

Substances chimiques

Antigens, CD34 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

164

Références

Biosci Rep. 2012 Jun;32(3):241-69
pubmed: 22458844
J Immunol Methods. 2009 Aug 15;347(1-2):70-8
pubmed: 19567251
Blood. 2015 Apr 23;125(17):2621-9
pubmed: 25762174
Science. 2011 Jul 8;333(6039):218-21
pubmed: 21737740
Blood. 1996 May 15;87(10):4120-8
pubmed: 8639769
Blood. 1992 Jul 15;80(2):429-36
pubmed: 1378320
J Hematother Stem Cell Res. 2001 Dec;10(6):807-14
pubmed: 11798507
Hum Gene Ther. 1994 Mar;5(3):295-305
pubmed: 7517188
Cell. 2002 Sep 20;110(6):673-87
pubmed: 12297042
Stem Cells. 2013 Feb;31(2):360-71
pubmed: 23165626
Cell Stem Cell. 2007 Dec 13;1(6):635-45
pubmed: 18371405
Stem Cell Reports. 2014 Nov 11;3(5):707-15
pubmed: 25418718
Immunology. 2012 Apr;135(4):268-75
pubmed: 22211918
Lab Invest. 2010 Apr;90(4):599-610
pubmed: 20142805
Mol Cell Biol. 2003 Dec;23(24):9349-60
pubmed: 14645544
Hematology. 2000;5(4):295-302
pubmed: 11399626
Exp Hematol. 1995 Dec;23(14):1535-42
pubmed: 8542944
Biorheology. 2003;40(1-3):189-95
pubmed: 12454404

Auteurs

Cristina Mesa-Núñez (C)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain.

Diego Leon-Rico (D)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain.

Montserrat Aldea (M)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain.

Carlos Damián (C)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain.

Raquel Sanchez-Baltasar (R)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain.

Rebeca Sanchez (R)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain.

Omaira Alberquilla (O)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain.

José Carlos Segovia (JC)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain.

Juan Antonio Bueren (JA)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain.

Elena Almarza (E)

Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Av. Complutense 40, 28040, Madrid, Spain. elenaalmarza@gmail.com.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melchor Fernández Almagro 3, 28029, Madrid, Spain. elenaalmarza@gmail.com.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS- FJD, UAM), Av. de los Reyes Católicos 2, 28040, Madrid, Spain. elenaalmarza@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH